2/3
08:03 am
tbph
Theravance Biopharma (NASDAQ:TBPH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $40.00 price target on the stock.
Low
Report
Theravance Biopharma (NASDAQ:TBPH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $40.00 price target on the stock.
1/24
05:10 am
tbph
Theravance Biopharma (NASDAQ:TBPH) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Theravance Biopharma (NASDAQ:TBPH) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
1/3
01:08 am
tbph
Theravance Biopharma (NASDAQ:TBPH) was downgraded by analysts at
Wall St
Low
Report
Theravance Biopharma (NASDAQ:TBPH) was downgraded by analysts at
Wall St
12/14
01:27 am
tbph
Theravance Biopharma (NASDAQ:TBPH) was upgraded by analysts at
Wall Stre
Medium
Report
Theravance Biopharma (NASDAQ:TBPH) was upgraded by analysts at
Wall Stre
12/12
09:35 am
tbph
Why The Narrative Around Theravance Biopharma Is Shifting After Trelegy Monetization And Strategic Review [Yahoo! Finance]
Low
Report
Why The Narrative Around Theravance Biopharma Is Shifting After Trelegy Monetization And Strategic Review [Yahoo! Finance]
12/6
01:36 am
tbph
Theravance Biopharma (NASDAQ:TBPH) was downgraded by analysts at
Wall St
Medium
Report
Theravance Biopharma (NASDAQ:TBPH) was downgraded by analysts at
Wall St
12/5
07:03 pm
tbph
Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-Term [Yahoo! Finance]
Medium
Report
Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-Term [Yahoo! Finance]
12/3
07:02 am
tbph
Theravance Biopharma (NASDAQ:TBPH) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
Low
Report
Theravance Biopharma (NASDAQ:TBPH) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.